Scinai Immunotherapeutics Ltd. - SCNI
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | History | Reduced | 121,785 | 63 | 0.0% | 0.0% | 1 | -109,111 | -47.26% | Q1 2024 | May 15, 2024 |
| CITADEL ADVISORS LLC | History | New | 12,214 | 6 | 0.0% | — | 2 | +12,214 | New | Q1 2024 | May 15, 2024 |
| MILLENNIUM MANAGEMENT LLC | History | New | 10,613 | 5 | 0.0% | — | 3 | +10,613 | New | Q1 2024 | May 15, 2024 |
| RHUMBLINE ADVISERS | History | Added to | 6,654 | 3 | 0.0% | 0.0% | 4 | +1,340 | 25.22% | Q1 2024 | May 09, 2024 |
| MORGAN STANLEY | History | Reduced | 2,579 | 1 | 0.0% | 0.0% | 5 | -3 | -0.12% | Q1 2024 | May 15, 2024 |
| UBS Group AG | History | Added to | 2,118 | 1 | 0.0% | 0.0% | 6 | +1 | 0.05% | Q1 2024 | May 13, 2024 |
| WELLS FARGO & COMPANY/MN | History | Closed out | 0 | 0 | — | — | — | -20 | -100.0% | Q1 2024 | May 10, 2024 |
| ROYAL BANK OF CANADA | History | No change | 4 | 0 | — | — | — | 0 | 0.0% | Q1 2024 | Nov 05, 2024 |
| CREDIT AGRICOLE S A | History | No change | 424 | 0 | — | — | — | 0 | 0.0% | Q1 2024 | May 14, 2024 |
| Qube Research & Technologies Ltd | History | No change | 7 | 0 | — | — | — | 0 | 0.0% | Q1 2024 | May 14, 2024 |
| Global Retirement Partners, LLC | History | No change | 50 | 0 | — | — | — | 0 | 0.0% | Q1 2024 | Apr 23, 2024 |